Evidence map›Paper›PMID 27423816›Full record

ReviewExperimental hematology2016

Inflammatory signals in HSPC development and homeostasis: Too much of a good thing?

Tiago C Luis, Cedric S Tremblay, Markus G Manz, Trista E North, Katherine Y King, Grant A Challen

Open access · greenAbstract readReview
In one paragraph

Review in Experimental hematology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Mesenchymal stromal cells improve the transplantation outcome of CRISPR-Cas9 gene-edited human HSPCs.Molecular therapy : the journal of the American Society of Gene Therapy · 2023
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Regulation of stress-induced hematopoiesis.Current opinion in hematology · 2020
    Review
  7. Hematopoietic Stem/Progenitor Cells and the Pathogenesis of HIV/AIDS.Frontiers in cellular and infection microbiology · 2020
    Review
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 6 institutions in 4 countries.

Tiago C LuisWeatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Headington, Oxford, United Kingdom.
Cedric S TremblayAustralian Centre for Blood Diseases, Monash University, Melbourne, Australia.
Markus G ManzDivision of Hematology, University Hospital and University of Zurich, Zurich, Switzerland.
Trista E NorthDepartment of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA.
Katherine Y KingSection of Infectious Diseases, Center for Cell and Gene Therapy, Department of Pediatrics, Baylor College of Medicine, Houston, TX.
Grant A ChallenSection of Stem Cell Biology, Division of Oncology, Department of Medicine, Washington University in St. Louis School of Medicine, St. Louis, MO. Electronic address: gchallen@DOM.wustl.edu.
Australian Centre for HIV and Hepatitis Virology Research · AUBaylor College of Medicine · USBeth Israel Deaconess Medical Center · USJohn Radcliffe Hospital · GBUniversity of Zurich · CHWashington University in St. Louis · US

Funding

Inflammatory Regulation of Hematopoietic Stem and Progenitor Cells to Enhance Innate ImmunityR01HL134880 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI KING, KATHERINE YUDEH · 2017 to 2020
$1.6M
The Role of Interferon-gamma in the Regulation of Hematopoietic Stem CellsK08HL098898 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI KING, KATHERINE YUDEH · 2010 to 2014
$653k
NHLBI NIH HHS K08 HL098898NHLBI NIH HHS R01 HL134880
6 · The paper itself

Abstract

Hematopoietic stem cells (HSCs) reside in the bone marrow and are responsible for the lifetime maintenance of the blood and bone marrow, achieved through their differentiation into the myriad cellular components and their ability to generate additional stem cells via self-renewal. Identification of intrinsic and extrinsic factors that regulate how the HSC population is maintained over the lifespan of an organism, or those that trigger differentiation into mature hematopoietic cell types, are important goals for regenerative medicine. Recent studies have found that inflammatory signals play a role in the regulation of adult HSC homeostasis and tonic innate immune signals influence HSC development during embryogenesis. Additionally, dysregulation of inflammatory cytokines, and the consequent impact of this on hematopoietic progenitors, may be a contributing factor to the hematopoietic defects that occur during aging and in patients with bone marrow failure syndromes or blood cancers. To update recent findings on this topic, the International Society for Experimental Hematology (ISEH) organized a webinar entitled "The Role of Inflammatory Signals in Embryonic HSC Development and Adult HSC Function," which we summarize here.

Indexed as

HematopoiesisHomeostasisSignal TransductionAnimalsCell DifferentiationCell ProliferationCytokinesHematopoietic Stem CellsHost-Pathogen InteractionsHumansInflammation MediatorsCytokinesInflammation Mediators

Identifiers

PMID27423816
PMCPMC6552661
OpenAlexW2475163493

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.